Header cover image

Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Defensive Stocks

Hong Kong Pharmaceuticals & Biotech Defensive Stocks

Results

9

0 new

Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.

9 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	1530 3SBio	HK$5.69	0%	-21.6%	HK$13.4b	HK$7.97	PE7.5x	E14.6%	4.3%
	1530 3SBio	HK$5.69	0%	-21.6%	HK$13.4b	HK$7.97	PE7.5x	E14.6%	4.3%
	1530 3SBio	HK$5.69	0%	-21.6%	HK$13.4b	HK$7.97	PE7.5x	E14.6%	4.3%
	2005 SSY Group	HK$3.57	-6.3%	-26.1%	HK$10.6b	HK$5.98	PE7.7x	E6.8%	5.0%
	2005 SSY Group	HK$3.57	-6.3%	-26.1%	HK$10.6b	HK$5.98	PE7.7x	E6.8%	5.0%
	2005 SSY Group	HK$3.57	-6.3%	-26.1%	HK$10.6b	HK$5.98	PE7.7x	E6.8%	5.0%
	512 Grand Pharmaceutical Group	HK$4.55	2.2%	2.5%	HK$15.9b	HK$5.80	PE6.6x	E2.3%	5.7%
	512 Grand Pharmaceutical Group	HK$4.55	2.2%	2.5%	HK$15.9b	HK$5.80	PE6.6x	E2.3%	5.7%
	512 Grand Pharmaceutical Group	HK$4.55	2.2%	2.5%	HK$15.9b	HK$5.80	PE6.6x	E2.3%	5.7%

Page 1 of 1